Financer l’innovation : conditionner le risque à la rente
In this interview, Théo Bourgeron elucidates the mechanisms employed by investment funds to fund innovation. Leveraging insights from his recent research on finance and the pharmaceutical industry, he emphasizes how, despite some mild resistance, this financing approach is underpinned by a historica...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Article ou chapitre numérique |
| 言語: | Français |
| 出版事項: |
2024
|
| 主題: | |
| オンライン･アクセス: | Accès Université d'Orléans et IFPM Accès Université d'Orléans et IFPM |
| 要約: | In this interview, Théo Bourgeron elucidates the mechanisms employed by investment funds to fund innovation. Leveraging insights from his recent research on finance and the pharmaceutical industry, he emphasizes how, despite some mild resistance, this financing approach is underpinned by a historically cross-party consensus, thereby constraining the proliferation of critics and alternative methods. |
|---|